182 related articles for article (PubMed ID: 23595658)
1. The association between TP53 Arg72Pro polymorphism and lung cancer susceptibility: evidence from 30,038 subjects.
Qiao Q; Hu W
Lung; 2013 Aug; 191(4):369-77. PubMed ID: 23595658
[TBL] [Abstract][Full Text] [Related]
2. Cigarette smoking, TP53 Arg72Pro, TP53BP1 Asp353Glu and the risk of lung cancer in a Japanese population.
Kiyohara C; Horiuchi T; Miyake Y; Takayama K; Nakanishi Y
Oncol Rep; 2010 May; 23(5):1361-8. PubMed ID: 20372852
[TBL] [Abstract][Full Text] [Related]
3. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.
Szymanowska A; Jassem E; Dziadziuszko R; Borg A; Limon J; Kobierska-Gulida G; Rzyman W; Jassem J
Lung Cancer; 2006 Apr; 52(1):9-14. PubMed ID: 16499995
[TBL] [Abstract][Full Text] [Related]
4. The TP53 Arg72Pro polymorphism and lung cancer risk in a population of Northern Spain.
Fernández-Rubio A; López-Cima MF; González-Arriaga P; García-Castro L; Pascual T; Marrón MG; Tardón A
Lung Cancer; 2008 Sep; 61(3):309-16. PubMed ID: 18336951
[TBL] [Abstract][Full Text] [Related]
5. TP53 Arg72Pro polymorphism and lung cancer risk: a meta-analysis.
Yan L; Zhang D; Chen C; Mao Y; Xie Y; Li Y; Huang Y; Han B
Int J Cancer; 2009 Dec; 125(12):2903-11. PubMed ID: 19623649
[TBL] [Abstract][Full Text] [Related]
6. P53 codon 72 polymorphism and lung cancer risk: evidence from 27,958 subjects.
Zhou C; Chen H; Wang A
Tumour Biol; 2013 Oct; 34(5):2961-9. PubMed ID: 23715779
[TBL] [Abstract][Full Text] [Related]
7. Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms.
Popanda O; Edler L; Waas P; Schattenberg T; Butkiewicz D; Muley T; Dienemann H; Risch A; Bartsch H; Schmezer P
Lung Cancer; 2007 Jan; 55(1):25-34. PubMed ID: 17059853
[TBL] [Abstract][Full Text] [Related]
8. Association between the TP53 polymorphisms and lung cancer risk: a meta-analysis.
Ye XH; Bu ZB; Feng J; Peng L; Liao XB; Zhu XL; Sun XL; Yu HG; Yan DF; Yan SX
Mol Biol Rep; 2014 Jan; 41(1):373-85. PubMed ID: 24271138
[TBL] [Abstract][Full Text] [Related]
9. TP53 Arg72Pro and XPD Lys751Gln Gene Polymorphisms and Risk of Lung Cancer in Bangladeshi Patients.
Nairuz T; Rahman M; Bushra MU; Kabir Y
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2091-2098. PubMed ID: 32711437
[TBL] [Abstract][Full Text] [Related]
10. Ethnicity-specific association between TERT rs2736100 (A > C) polymorphism and lung cancer risk: a comprehensive meta-analysis.
Wu X; Huang G; Li W; Chen Y
Sci Rep; 2023 Aug; 13(1):13271. PubMed ID: 37582820
[TBL] [Abstract][Full Text] [Related]
11. A meta-analysis of TP53 codon 72 polymorphism and lung cancer risk: evidence from 15,857 subjects.
Li Y; Qiu LX; Shen XK; Lv XJ; Qian XP; Song Y
Lung Cancer; 2009 Oct; 66(1):15-21. PubMed ID: 19178978
[TBL] [Abstract][Full Text] [Related]
12. P53 polymorphism and lung cancer susceptibility: a pooled analysis of 32 case-control studies.
Dai S; Mao C; Jiang L; Wang G; Cheng H
Hum Genet; 2009 Jun; 125(5-6):633-8. PubMed ID: 19357867
[TBL] [Abstract][Full Text] [Related]
13. Association of TP53 Codon 72 Arg>Pro Polymorphism with Breast and Lung Cancer Risk in the South Asian Population: A Meta-Analysis.
Jafrin S; Aziz MA; Anonna SN; Akter T; Naznin NE; Reza S; Islam MS
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1511-1519. PubMed ID: 32592343
[TBL] [Abstract][Full Text] [Related]
14. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and bladder cancer risk.
Liu ZH; Bao ED
Mol Biol Rep; 2013 Mar; 40(3):2389-95. PubMed ID: 23184052
[TBL] [Abstract][Full Text] [Related]
15. Arg72Pro polymorphism of TP53 gene and the risk of skin cancer: a meta-analysis.
Ye J; Li XF; Wang YD; Yuan Y
PLoS One; 2013; 8(11):e79983. PubMed ID: 24260330
[TBL] [Abstract][Full Text] [Related]
16. Investigation on the role of p53 codon 72 polymorphism and interactions with tobacco, betel quid, and alcohol in susceptibility to cancers in a high-risk population from North East India.
Ihsan R; Devi TR; Yadav DS; Mishra AK; Sharma J; Zomawia E; Verma Y; Phukan R; Mahanta J; Kataki AC; Kapur S; Saxena S
DNA Cell Biol; 2011 Mar; 30(3):163-71. PubMed ID: 21043833
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer.
Zhang X; Miao X; Guo Y; Tan W; Zhou Y; Sun T; Wang Y; Lin D
Hum Mutat; 2006 Jan; 27(1):110-7. PubMed ID: 16287156
[TBL] [Abstract][Full Text] [Related]
18. Association between TP53 Arg72Pro polymorphism and thyroid carcinoma risk.
Wang F; Wang P; Wang B; Fu ZJ; Yuan Y; Yan SL; Zhao WJ; Wang YG
Tumour Biol; 2014 Mar; 35(3):2723-8. PubMed ID: 24375191
[TBL] [Abstract][Full Text] [Related]
19. p53 codon 72 polymorphism is associated with susceptibility to hepatocellular carcinoma in the Turkish population: a case-control study.
Sümbül AT; Akkız H; Bayram S; Bekar A; Akgöllü E; Sandıkçı M
Mol Biol Rep; 2012 Feb; 39(2):1639-47. PubMed ID: 21607615
[TBL] [Abstract][Full Text] [Related]
20. Association between the hOGG1 Ser326Cys polymorphism and lung cancer susceptibility: a meta-analysis based on 22,475 subjects.
Xu Z; Yu L; Zhang X
Diagn Pathol; 2013 Aug; 8():144. PubMed ID: 23971971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
